3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
32
Ovarian Neoplasms
21
Neoplasms
14
Carcinoma, Hepatocellular
13
Fallopian Tube Neoplasms
12
Carcinoma, Non-Small-Cell Lung
9
Endometrial Neoplasms
7
Colonic Neoplasms
7
Neoplasm Metastasis
6
Squamous Cell Carcinoma of Head and Neck
4
Glioblastoma
4
Breast Neoplasms
4
Brain Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Rectal Neoplasms
3
Lung Neoplasms
3
Liver Neoplasms
3
Biliary Tract Neoplasms
3
Sarcoma
2
Recurrence
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Pancreatic Neoplasms
2
Neuroma, Acoustic
2
Neurofibromatosis 2
2
Mouth Neoplasms
2
Meningioma
2
Lymphoid Interstitial Pneumonia
2
Gastrointestinal Neoplasms
2
Digestive System Neoplasms
2
Interventions
Cisplatin
6
Paclitaxel
4
pembrolizumab
3
Fluorouracil
3
Carboplatin
3
tislelizumab
2
Taxes
2
Radiotherapy
2
Oxaliplatin
2
Leucovorin
2
Irinotecan
2
Injections
2
Capecitabine
2
130-nm albumin-bound paclitaxel
2
spartalizumab
1
lenvatinib
1
durvalumab
1
cixutumumab
1
apatinib
1
Tegafur
1
Surgical Procedures, Operative
1
Saline Solution
1
Radiation
1
Levoleucovorin
1
Laparoscopy
1
Histamine H2 Antagonists
1
Histamine Antagonists
1
Fulvestrant
1
Docetaxel
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Bevacizumab
×
30 days
×
Clear all
No trials found.